CHIMERGEN Trademark

Trademark Overview

On Saturday, January 11, 2025, a trademark application was filed for CHIMERGEN with the United States Patent and Trademark Office. The USPTO has given the CHIMERGEN trademark a serial number of 98952599. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, January 11, 2025. This trademark is owned by CHIMERGEN THERAPEUTICS INC.. The CHIMERGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of cancer, autoimmune diseases, inflammatory conditions, central nervous system (CNS) disorders, and other human diseases; pharmaceutical preparations for degrading disease-causing and pathogenic proteins via lysosomal targeting, ubiquitin-proteasome pathways, or other cellular degradation mechanisms; therapeutic agents for the prevention and treatment of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease; pharmaceutical preparations for the treatment of chronic and acute pain conditions, including neuropathic pain and inflammatory pain; pharmaceutical preparations for the treatment of immune-mediated diseases, including rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis; Pharmaceutical preparations for the treatment of lysosomal storage disorders; and pharma...

Research and development in the pharmaceutical and biotechnology fields
chimergen

General Information

Serial Number98952599
Word MarkCHIMERGEN
Filing DateSaturday, January 11, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateSaturday, January 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of cancer, autoimmune diseases, inflammatory conditions, central nervous system (CNS) disorders, and other human diseases; pharmaceutical preparations for degrading disease-causing and pathogenic proteins via lysosomal targeting, ubiquitin-proteasome pathways, or other cellular degradation mechanisms; therapeutic agents for the prevention and treatment of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease; pharmaceutical preparations for the treatment of chronic and acute pain conditions, including neuropathic pain and inflammatory pain; pharmaceutical preparations for the treatment of immune-mediated diseases, including rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis; Pharmaceutical preparations for the treatment of lysosomal storage disorders; and pharmaceutical preparations for research and clinical use in protein degradation-based therapies targeting pathogenic proteins in diverse disease states.
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 11, 2025
Primary Code005
First Use Anywhere DateFriday, January 10, 2025
First Use In Commerce DateFriday, January 10, 2025
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 11, 2025
Primary Code042
First Use Anywhere DateWednesday, January 1, 2025
First Use In Commerce DateThursday, January 2, 2025

Trademark Owner History

Party NameCHIMERGEN THERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWalnut Creek, CA 94597

Trademark Events

Event DateEvent Description
Saturday, January 11, 2025NEW APPLICATION ENTERED
Saturday, January 11, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

chimergen pharmaceutical treatment disease preparations diseases inflammatory pain including lysosomal disorders